Looking to the Future :

As we move into the 21st century, Vee Excel Drugs and Pharmaceuticals is continuing to explore new ways to bring innovative, effective medications to patients and the HealthCare community.  Vee Excel Drugs and Pharmaceuticals brings new value to products by reinventing the industry’s approach to form and formulation, with deep scientific expertise in form and formulation, state-of-art high-throughput experimentation and informatics to maximize the clinical and commercial value. Vee Excel Drugs and Pharmaceuticals is distinctively positioned to expedite drug development to bring new and better products to the market, and the patients we ultimately serve.

And we are leveraging our leadership in this space to rapidly develop a pipeline of our own proprietary products 

 Vee Excel Drugs and Pharmaceuticals has a multi-product portfolio with each program representing a distinct chemical family, mechanism of action, and therapeutic category. This profile diversifies the product, regulatory, and market risks of our pipeline, while still capturing the synergies of one engine driving discovery and development.

Category-leading potential:

Our products target major unmet needs in large therapeutic markets. These compounds have the potential to establish major new therapeutic franchises. We believe our first-mover advantages, proprietary knowledge, strong intellectual property position, and fully-integrated discovery engine increase our competitive advantage within the franchise. Our goal is to be best-in-class in addition to first-in-class.